Stock ROVI LABORATORIOS FARMACEUTICOS ROVI, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Laboratorios Farmaceuticos Rovi, S.A.

Equities

ROVI

ES0157261019

Market Closed - BME
Other stock markets
 11:35:13 2024-05-21 am EDT 		After market 03:52:22 pm
88.2 EUR +0.46% Intraday chart for Laboratorios Farmaceuticos Rovi, S.A. 88.32 +0.14%
May. 08 Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 02 Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment MT
d53dc88579d96b83f08f0.VGH_pdOhwZ0XQF_v0gHgzcTLl4lW49rDHwRP-Roxxjs.AjSv0Orz8folMzqHh1GCo6KU5vFvjpvxcTI9iHVXgQMFFauW4_KDrXp4OA~4a5d65996432bd642d7619551f570287
  1. Stock Market
  2. Equities
  3. ROVI Stock
  4. Charts Laboratorios Farmaceuticos Rovi, S.A.
  5. News Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW